• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Indonesia·Consumer Defensive·CLEO.JK
Share

PT Sariguna Primatirta Tbk Stocks

IDR 374Last Updated 10.11.2026

Issuer Rating

3/7
Performance

Average

Risk

High

Recommendation

Sell

Market Cap

IDR 532.80M

IDR 374
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very strong margins and returns

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

PT Sariguna Primatirta Tbk is an Indonesian corporation primarily involved in the bottled drinking water industry. The company organizes its operations across distinct segments, including Bottle, Non-Bottle, and other categories. It offers a diverse range of drinking water products, marketed under brands such as Anda, Cleo Platine, S-Tube, Super O2, Vio 8+, and Cleo Pure Water. Established in 1988, the firm was initially known as PT Sari Guna before adopting its present name, PT Sariguna Primatirta Tbk, in December of the same year. Its main corporate office is located in Sidoarjo, Indonesia, and it operates as a subsidiary of PT Tancorp Global Abadi.

Company Valuation

Greatly overvalued
1/7

Considering past and projected metrics, the stock is distinctly 'expensive' compared to its peers. Specifically, the stock is 'expensive' on P/E, neutral on EV/EBITDA, ov

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Favourable
6/7

The average target price of CLEO.JK is 620 and suggests 69.4% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to in

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

11.11.2026 05:26

Nebius's Nvidia-backed competitor may postpone its IPO — The Telegraph

11.11.2026 02:45

CoreWeave exceeded Wall Street's expectations. Will this ease concerns about neo-clouds?

11.11.2026 02:17

Stocks fell, and bonds experienced one of their biggest sell-offs: the market is waiting for the Fed to act

11.11.2026 01:51

Money managers seek shelter from AI risks in emerging markets. What are they buying?

11.11.2026 00:09

Boeing books most October aircraft orders in almost three decades

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026